Search IPOs
Grey Market Premium · May 21 – May 25, 2026 · Issue Price ₹349
The Q-Line Biotech IPO GMP today is ₹124.00, indicating 35.5% expected listing gain.
The Q-Line Biotech IPO Grey Market Premium (GMP) is currently trading at ₹124.00 in the unofficial grey market. Based on this, the expected listing price is ₹473.00, implying a +35.5% gain over the issue price of ₹349. GMP reflects pre-listing demand from grey market participants and is a widely tracked sentiment indicator among IPO investors.
Grey market premium over time (₹)
Latest 12 data points, most recent first
| Date / Time | GMP (₹) | Exp. Listing | Exp. Gain |
|---|---|---|---|
| May 28, 2026 10:36 am | +₹124.00 | ₹473.00 | +35.5% |
| May 27, 2026 5:20 pm | +₹124.00 | ₹473.00 | +35.5% |
| May 26, 2026 4:21 pm | +₹108.00 | ₹457.00 | +30.9% |
| May 25, 2026 9:32 pm | +₹101.00 | ₹450.00 | +28.9% |
| May 24, 2026 10:14 pm | +₹125.00 | ₹474.00 | +35.8% |
| May 23, 2026 1:56 pm | +₹130.00 | ₹479.00 | +37.2% |
| May 22, 2026 5:55 pm | +₹120.00 | ₹469.00 | +34.4% |
| May 21, 2026 10:35 pm | +₹117.00 | ₹466.00 | +33.5% |
| May 20, 2026 10:00 pm | +₹141.00 | ₹490.00 | +40.4% |
| May 19, 2026 5:38 pm | +₹110.00 | ₹459.00 | +31.5% |
| May 18, 2026 12:02 pm | +₹69.00 | ₹418.00 | +19.8% |
| May 17, 2026 6:26 pm | +₹0.00 | ₹349.00 | +0.0% |
Want to understand how GMP works and how to estimate listing price? Read our guide on What is GMP in IPO.
The current Grey Market Premium for Q-Line Biotech IPO is ₹124.00 as of May 28, 2026. Expected listing price: ₹473.00, expected gain: 35.5%. GMP data is updated periodically from grey market sources.
A GMP of ₹124.00 means that in the unofficial grey market, Q-Line Biotech IPO shares are trading at ₹124.00 above the issue price. With an issue price of ₹349, this implies an expected listing at ₹473.00 (35.5% gain). GMP is purely indicative and actual listing price depends on market conditions.
GMP is an unofficial, unregulated indicator from the informal grey market. It reflects speculative pre-listing demand but can be manipulated or change rapidly. Use it as one data point alongside official subscription data, company financials, and valuation metrics. SEBI does not regulate grey market trading.
Q-Line Biotech IPO is expected to list on May 29, 2026 on NSE SME platform. The GMP on listing day is a strong short-term indicator of opening price.
GMP is unofficial and unregulated. Past GMP accuracy varies. Use alongside subscription data and fundamentals.
